Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?

Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?

Anti-tumor necrosis factor (TNF) biological therapy has generally been accepted as a standard therapeutic option in inflammatory bowel disease (IBD) patient who are refractory to steroids or immunomodulators. However, the primary and secondary nonresponse rates to anti-TNF bioagents in patients with...

Full description

Bibliographic Details
Main Authors:	Guanglin Cui, Jon Florholmen, Rasmus Goll
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Immunology
Subjects:	mucosa tumor necrosis factor inflammatory bowel disease anti-TNF therapy biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.881112/full

Similar Items

Intensified anti-TNF treatment downregulates the phenotype in ulcerative colitis: a 13-year prospective follow-up study
by: Jon Florholmen, et al.
Published: (2024-01-01)

Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
by: Kay-Martin Johnsen, et al.
Published: (2022-11-01)

Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
by: Jon R. Florholmen, et al.
Published: (2020-10-01)

Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke
by: Cui Guanglin, et al.
Published: (2012-10-01)

TNF superfamily control of tissue remodeling and fibrosis
by: Hope Steele, et al.
Published: (2023-07-01)

The impact of Lidocaine gel on TNF-α expression in surgically induced oral mucosal ulcers: an immunohistochemical analysis in rabbits
by: Hamed Rayan S., et al.
Published: (2023-01-01)

Evaluation of absolute quantitation by nonlinear regression in probe-based real-time PCR
by: Olsen Trine, et al.
Published: (2006-03-01)

Ulcerative colitis: functional analysis of the in-depth proteome
by: Armin Schniers, et al.
Published: (2019-01-01)

Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study
by: Mohammad Hossein Derakhshan Nazari, et al.
Published: (2023-11-01)

Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
by: Sherman Picardo, et al.
Published: (2020-06-01)

ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis
by: Guanglin Cui, et al.
Published: (2020-04-01)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
by: Xuefei Li, et al.
Published: (2023-10-01)

A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease
by: Guanglin Cui, et al.
Published: (2018-06-01)

Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease
by: Irene Soleto, et al.
Published: (2022-08-01)

MEDICINAL FORM OF TNF-α FOR LOCAL ADMINISTRATION
by: S. G. Gamaley, et al.
Published: (2012-05-01)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
by: Dan-in Jang, et al.
Published: (2021-03-01)

Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFα as mediators of neuronal hyperexcitability
by: Sarah E. Barnes, et al.
Published: (2021-09-01)

Reproductive effects of the tumor necrosis factor (TNF) deficiency in mice
by: S. O. Maslennikova, et al.
Published: (2015-12-01)

The TNF Paradox in Cancer Progression and Immunotherapy
by: Anne Montfort, et al.
Published: (2019-07-01)

Reverse Signaling Contributes to Control of Chronic Inflammation by Anti-TNF Therapeutics
by: Orsolya Sipos, et al.
Published: (2015-06-01)

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
by: Marcin Sochal, et al.
Published: (2021-10-01)

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
by: Anne Montfort, et al.
Published: (2019-10-01)

Evaluation of tumor necrosis factor-α (TNF-α) levels in plasma and their correlation with periodontal status in obese and non-obese subjects
by: Khanna Suruchi, et al.
Published: (2010-01-01)

Importance of TNF-alpha in the course of acute infection with Trypanosoma cruzi: influence of its inhibition by pentoxifylline treatment
by: Sonia G Andrade, et al.
Published: (2008-02-01)

Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
by: Javier P. Gisbert, et al.
Published: (2021-11-01)

Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis
by: Olivia Patsalos, et al.
Published: (2020-04-01)

Effect of huankuile on colon injury in rats with ulcerative colitis by reducing TNF-α and MMP9
by: Xilinguli Wushouer, et al.
Published: (2024-02-01)

Mucosal relapse of visceral leishmaniasis in a child treated with anti-TNFα
by: E. Jeziorski, et al.
Published: (2015-04-01)

Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections
by: Andy Ruiz, et al.
Published: (2021-05-01)

Risk of neutropenia in inflammatory bowel disease patients treated with TNF inhibitors: A single-center, retrospective cohort study
by: Dimah AlAskar, et al.
Published: (2020-01-01)

Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
by: Tim van der Houwen, et al.
Published: (2020-04-01)

The Relationship between Mucins and Ulcerative Colitis: A Systematic Review
by: Esther Bankole, et al.
Published: (2021-04-01)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017-07-01)

The Function and Therapeutic Implications of TNF Signaling in MDSCs
by: Kun Yu, et al.
Published: (2022-11-01)

The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
by: Francis Okeke, et al.
Published: (2020-08-01)

ROLE OF TNFα/TNF-R1-SIGNALING PATHWAY IN CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST GLIOBLASTOMA CELL LINES
by: T. V. Tyrinova, et al.
Published: (2018-06-01)

Relationship between Dynamics of TNF-α and Its Soluble Receptors in Saliva and Periodontal Health State
by: Ryota Kibune, et al.
Published: (2022-02-01)

Neuroimmune Mechanisms Underlying Neuropathic Pain: The Potential Role of TNF-α-Necroptosis Pathway
by: Yi-Wen Duan, et al.
Published: (2022-06-01)

Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
by: Guanglin Cui, et al.
Published: (2021-10-01)

Evaluation of TNF alpha G308A promoter gene polymorphism and serum TNF alpha levels in patients with inflammatory bowel disease in Turkish population
by: Resul Kahraman, et al.
Published: (2019-12-01)